Hangama Abassi, NP

Hangama Abassi practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Hangama Abassi's NPI, 1487083655, was assigned on November 7, 2013. Hangama Abassi holds California license 95000027.

Hangama Abassi's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Hangama Abassi's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. Hangama Abassi is also affiliated with Concord Medical Center. The medical group on file is John Muir Medical Group. Dmand AI also links Hangama Abassi to 2 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hangama Abassi practices, 6 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Hangama Abassi's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Hangama Abassi is board certified in acute care nurse practitioner by the American Nurses Credentialing Center. Hangama Abassi is licensed in California.

CMS data shows 14 Medicare services from Hangama Abassi across 1 procedure code in 2024, for 15 Medicare patients. Medicare paid $795 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Hangama Abassi in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hangama Abassi's median patient age at 64, with 60% women.

In 2024, Hangama Abassi wrote 143 Medicare Part D claims for 28 patients. 92% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $15,230 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Hangama Abassi for performance year 2024, reported through an alternative payment model (APM). Hangama Abassi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 73 general payments to Hangama Abassi from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $244.

Hangama Abassi is a member of ACNP.